Mentara Therapeutics Launches MTA-304 to Combat Dyskinesia in Parkinson's Patients #Australia #Sydney #SPRIM_Global_Investments #Mentara_Therapeutics #PDE10A_Inhibitor
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialMentara Therapeutics Launches MTA-304 to Combat Dyskinesia in Parkinson's Patients #Australia #Sydney #SPRIM_Global_Investments #Mentara_Therapeutics #PDE10A_Inhibitor